NEWS & ANNOUNCEMENTSThe work,
The work,
in progress.
All nine published Ibex announcements, available here on the local site.
DISCOVERY-DRIVEN BIOTECHNOLOGYSCROLL TO EXPLORE ↓
FROM THE ARCHIVEStories from
Stories from
our journey.
Research milestones, company news, and publications from Ibex Biosciences.
2024 Future of Malaria Research Symposium
Ibex presents at the 2024 Future of Malaria Research Symposium at John Hopkins
Our New LinkedIn page
Ibex invites you to click on the LinkedIn logo to subscribe to our news feed.
Antibodies targeted to CD147
Ibex announces publication of Antibodies targeted to CD147 (patent pending)
Top Biotechnology Start-up award for 2022
Ibex receives a Top Biotechnology Start-up award for 2022 from Life Sciences Review Magazine.
PCBP1 use for generating Stem Cells
Ibex announces publication of PCBP1 use for generating Stem Cells while inhibiting oncogenesis (patent pending)
Phase I SBIR
Ibex announces completion of Phase 1 SBIR Grant
FILAMIN-A
Ibex announces publication of FILAMIN-A (patent pending)
PCBP1
Ibex announces publication of PCBP1
SBIR award
Ibex announces SBIR award